Harmony Biosciences Holdings Inc

HRMYNASDAQ · USD
37.95USD0.00 (-0.84%)
9710

Harmony Biosciences Holdings Inc (HRMY) Implied Volatility Current

HRMY implied volatility is 63%. IV Rank is 51%, placing current premiums in the middle of their 52-week range.

Read more

Tracking HRMY implied volatility helps you identify when options premiums on Harmony Biosciences Holdings Inc are historically cheap or expensive, and where the best trades are hiding. Harmony Biosciences Holdings Inc implied volatility reflects the market's expectation of future price movement: when HRMY IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Harmony Biosciences Holdings Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For HRMY, tracking metrics like HRMY IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on HRMY signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where HRMY implied volatility sits today versus where it has been. Our scanner ranks Harmony Biosciences Holdings Inc implied volatility against its historical range, surfaces extremes in HRMY IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Harmony Biosciences Holdings Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
50.79%IV Rank
Moderate

IV is slightly elevated - premiums are richer, leaning toward sellers.

Implied Volatility (30d)63.39%

IV Rank50.79%

Historical Volatility (30d)26.81%

IV - HV+36.58%

As of October 16, 2026

Trade options with IV on your side

Track HRMY IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial